[Retracted] Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Figure 4

DFS analysis of CDCA3 in pan-cancer. (a) The forest plot shows the univariate Cox analysis of CDCA3 gene in DFS of various tumor patients, including value, risk coefficient HR, and confidence interval. (b) Heatmap showing DFS of CDCA3 gene in pan-cancer. (c–n) Kaplan-Meier curves show DFS of CDCA3 gene in ACC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PCPG, PRAD, SARC, UCEC, and UVM.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)